Our Team
The Founders
Dr Lynne Lim The Founder
Lynne is a Senior Consultant Ear Nose Throat Surgeon, and Adj Assoc Professor and Visiting Consultant to the National University Health System Singapore. Her research fellowship and clinical sub-specialisation were in Paediatric ENT, Hearing, and Ear Reconstruction at Cincinnati Children Hospital Medical Centre, Stanford Medical Centre, University of Virginia Medical Centre and Nagata Plastic and Ear Reconstruction Clinic, Japan. She did her MPH at Harvard School of Public Health and is passionate about improving health outcomes for patients. Lynne was Vice- Dean at School of Medicine, National University Singapore, and Vice Chairman Medical Affairs at National University Hospital. She has pioneered several firsts in hearing implants surgery in Asia and Singapore, and was primary investigator for over SGD 14 million in competitive research grants. Lynne was founding director for the MSc Audiology program NUS, and for the Centre for Hearing Speech and Balance at NUHS. She set up the roving Minivan Hearing Service to improve access to hearing services for elderly heart-landers. She especially enjoyed the many opportunities to visit and teach in the APAC and Middle East neighbouring countries. Since 2014, Lynne has been in private ENT practice. She continues to be passionate about innovating to meet the real needs of patients.
www.drlynnelim.com
Mr Gan Chee WeeThe Founder
Chee Wee is currently the Chief Technical Officer with NousQ, overseeing the product realization process to translate innovative concepts into clinically and commercially viable products. Chee Wee graduated with B.Eng and M.Eng in Chemical and Biomolecular Engineering from the National University of Singapore, specializing in Biomolecular Engineering. His research interests are on drug delivery and MedTech / Biomedical innovation. He has led overall project grants management and the technical design, development and pre-clinical testing including various biological and cadaver models. Chee Wee has had extensive training and knowledge in quality management system and medical device regulatory affairs and has Engineering Technical Consultancy experience in other medical product development.
Mr Dennis LauChief Operating Officer
Dennis graduated from UNSW, Australia with a Masters in Biomedical Engineering and degree in Electrical Engineering. Shortly after graduating, he joined the medical device industry and has been in the industry for close to 2 decades. He lived in Sydney, Australia for more than a decade and started his career working for ResMed Australia. During his 15 years tenure with ResMed, he spent bulk of his time in R&D and successfully launched multiple new products before relocated to ResMed Singapore to lead the APAC commercial operations involving QARA, logistic, technical services, market expansions, business development and strategic partnerships. After ResMed, he went on to work for Cepheid, a diagnostics company under Danaher, to lead projects for market expansion in China before starting his startup journey with medical device company, Nasotrak Medical.
Mr Ricardo VillanuevaSenior Vice President, Strategy & Business Development
Ricardo is a finance and mergers & acquisitions (M&A”) professional. Prior to joining NousQ, he was the Head of M&A and Strategic Planning for IHH Healthcare. During his tenure, IHH Healthcare more than doubled the number of hospitals in its portfolio from 35 hospitals to become one of the world’s largest integrated private healthcare providers with 80 hospitals in 10 countries. Ricardo graduated in Economics and Finance with a BCA (Hons) from the Victoria University of Wellington. He also has an MBA from the University of Chicago’s Booth School of Business.
Mr Steven Wang Head of Commercialisation
Steven Wang is a healthcare business leader with over 20 years of experience in the medical device industry across Singapore and the Asia‑Pacific region. He began his career as a Registered Nurse in Emergency and Intensive Care before moving into senior commercial roles with multinational medical technology companies. His expertise spans ENT, Cardiovascular, Vascular, General Surgery, Orthopaedics, Robotic Surgery, and Women’s Health. With a Bachelor of Science (BSc) Hons in Health Sciences Nursing from Edinburgh Napier University, United Kingdom, Steven combines a strong clinical foundation with extensive commercial acumen to drive the successful introduction, expansion, and adoption of innovative medical technologies. He has a proven track record in market access, product commercialisation, strategic partnerships, clinical adoption, reimbursement strategy, key account management, and regional business development.
Ms Cecile RealBusiness & Strategy Advisor
MBiomed Eng, MBA. Cécile is an experienced entrepreneur in medical industry and management of start-ups. Co-founded her first start-up at age 25: Bioprofile, developing innovative solutions for arthritis. Rapidly expanded the company and gained strong experience in product development, business development and fund raising. Set up an international distribution network and integrated Bioprofile within a US SME, before acquisition by a larger company. She then co-founded Fluoptics and served as Interim CEO at Inatherys, two start-ups developing imaging solutions and a new drug to treat cancer. In 2011, Cecile co-founded Endodiag for endometriosis diagnosis and Medevice Capital, an entrepreneur seed fund specialized in medical device. She is passionate about innovation, impact and entrepreneurship and mentoring women entrepreneurs. Nominated Women Entrepreneur of the Year by France Biotech (2016), EU Women entrepreneur by the European commission (2016) and jury President of the Ilab competition 2022 (French National Innovation competition).
Mr Ng Tze-MauBusiness Development & Commercialisation Advisor
Professionally trained as a pharmacist, with postgraduate diploma in Marketing. Tze-Mau has built a thorough and in-depth understanding of the pharmaceutical and medical device industry. He has spent close to 30 successful years with 3 leading med-tech companies, namely Alcon, Cochlear and Zimmet Biomet, with progressively increased responsibilities in multiple countries, Southeast Asia and APAC.
Having started as a sales representative in 1996, and Tze-Mau has developed a wealth of hands-on experience in sales, marketing and management, from being a specialist, manager, sales director, country general manager, regional director, to VP of sales and APAC business unit, starting in Singapore, then China, Vietnam, Indonesia, Taiwan, USA, SE Asia and APAC. These ground-up and diverse experience, coupled with clear and pragmatic strategic and developmental thinking, authentic leadership and an inquisitive mindset. Tze-Mau continues to impact positively on business and people that he works with.
Mr Krzysztof LangerBusiness Development & Commercialisation Advisor
Ricardo is a finance and mergers & acquisitions (M&A”) professional. Prior to joining NousQ, he was the Head of M&A and Strategic Planning for IHH Healthcare. During his tenure, IHH Healthcare more than doubled the number of hospitals in its portfolio from 35 hospitals to become one of the world’s largest integrated private healthcare providers with 80 hospitals in 10 countries. Ricardo graduated in Economics and Finance with a BCA (Hons) from the Victoria University of Wellington. He also has an MBA from the University of Chicago’s Booth School of Business.
Mr Quek How JiangBoard of Directors
How Jiang is the CEO of Genedant Capital Pte Ltd, a Singapore-based investment company focused on the emerging science and technology sectors. He was previously an Executive Director at Octagon Advisors, a Singapore-founded specialist risk management consultancy to financial institutions. Prior to joining Octagon Advisors, How Jiang was a First Vice President in Singapore’s United Overseas Bank responsible for the business unit focused on the Bank’s key mass affluent retail customer segment, and concurrently its Investment Services Unit, tasked with developing UOB’s entire suite of wealth management products. Before joining UOB, How Jiang was the Senior Manager for Institutional Asset Management at Dresdner Asset Management (now part of Allianz Global Investors) based in its Singapore and Frankfurt units. How Jiang started his career at the Monetary Authority of Singapore (MAS), where he was responsible for the development of the Singapore financial centre. He was also the Staff Assistant to the Managing Director of MAS and the MAS Press Officer during his tenure. How Jiang is also a negotiation skills trainer, and has delivered courses to staff of MNCs in the region.
How Jiang was awarded the Overseas Undergraduate Scholarship by the Monetary Authority of Singapore for study at the London School of Economics and Political Science, where he graduated with a First Class Honours degree in Monetary Economics. He has passed all 3 levels of the Chartered Financial Analyst examinations.
Dr Pang Hau YunBoard of Directors
Dr. Nathan Pang has had 5 years of clinical experience and 20 years of leadership experience in the biopharmaceutical industry, which he first joined as Medical Director in Glaxo Wellcome Taiwan from 1998. In 2001 he served with Novartis Asia-Pacific as Regional Marketing Director, and later appointed in 2002 as Regional Head for Oncology Business Unit, Asia Pacific. Nathan has significant direct experience in China having spent nearly 15 years residing and working there. In 2006, Nathan was CEO of Sandoz China, the Generics Division of Novartis Group. From 2010 to 2014, Nathan served as the President for China, Sasteria. From 2014 to 2018 he served as GM China heading Sanofi Pasteur, the vaccines division of the Sanofi Group. After which he had his third tour of duty in China, appointed from Feb 2019 as CEO of AffaMed Therapeutics, a PE invested start up. Currently he is SVP, Asia Head for BioNTech.
Dr. Nathan Pang is a registered Medical Physician in Singapore; holds a dual EMBA from France’s INSEAD and China’s Tsinghua University, Bachelor of Law from University of London, as well as Bachelor of Medicine & Surgery from National University of Singapore.